INDIANA HEMOPHILIA & THROMBOSIS CENTER INC (EIN 352047838) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

AMY D SHAPIRO MD

Phone

3178710000

Tax Period

2024-01-01 to 2024-12-31

INDIANA HEMOPHILIA & THROMBOSIS CENTER INC, founded in 1998, is a mid-sized nonprofit in the Health Care sector that reported $39.4M in total revenue in fiscal year 2024. Revenue fell 31% from the prior year — a significant decline worth monitoring. Expenses of $45.2M exceeded revenue, resulting in a 15% operating deficit.

Mission

THE INDIANA HEMOPHILIA & THROMBOSIS CENTER, INC. IS COMMITTED TO PROVIDING THE HIGHEST QUALITY COMPREHENSIVE SERVICES AND HOLISTIC CARE TO PATIENTS WITH BLEEDING, CLOTTING AND OTHER HEMATOLOGIC DISORDERS, AND TO THEIR FAMILIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,491,579

Program Service Revenue $2,175,968

Investment Income $520,020

Other Revenue $34,233,008

TOTAL REVENUE $39,420,575

Expense Breakdown

Grants Paid $3,590,157

Salaries & Benefits $31,315,335

Fundraising Expenses $86,190

Program Expenses $41,675,734

Other Expenses $10,278,375

TOTAL EXPENSES $45,183,867

Year-over-Year Comparison

	2024	2023	Change
Revenue	$39,420,575	$56,975,342	-0.3%
Expenses	$45,183,867	$56,574,065	-0.2%
Net Income	$-5,763,292	$401,277	-15.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

306

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$4,255,596

Total Directors

$2,229,889

Key Employees

$290,110

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AMY D SHAPIRO MD	PRESIDENT/CEO, MEDICAL DIR	10.00	Officer Director	$211,406	$72,802	$1,095,913
ANNE GREIST MD	DIRECTOR, MEDICAL DIRECTOR	5.00	Officer Director	$92,143	$47,730	$524,676
DENNIS CASEY	DIRECTOR	2.00	Director	$9,000	$0	$80,500
EDWARD SCHMIDT	DIRECTOR	2.00	Director	$9,000	$0	$211,000
JAMES GILROY III	DIRECTOR	3.00	Director	$33,000	$0	$33,000
PHILLIP HIMELSTEIN	DIRECTOR	2.00	Director	$9,000	$0	$183,800
RUSSELL SHERLOCK	CHAIRMAN	3.00	Director	$13,500	$0	$101,000
CHRIS ROBERSON	CHIEF RESEARCH OFFICER/ SECRETARY	26.00	Officer	$208,198	$74,486	$428,141
ERIC GRAY	CHIEF OPERATIONS OFFICER	18.00	Officer	$180,878	$89,707	$550,542
JENNIFER MAAHS	DIRECTOR OF CLINICAL CARE	29.00	Officer	$189,274	$49,223	$344,309
KELLY MCCARTHY	DIR OF MULTIDISCIPLINARY T	31.00	Officer	$209,292	$75,538	$382,579
NANCY HOARD	EXECUTIVE DIRECTOR	17.00	Officer	$183,932	$47,175	$521,882
SANJYA AHUJA MD	CHIEF MEDICAL & INFORMATICS OFFICER	12.00	Officer	$34,128	$2,556	$126,401
KEVIN SIMMONS	CHIEF FINANCIAL OFFICER	37.00	Officer	$189,530	$49,040	$281,153
STEVAN MIZIMAKOSKI	DIRECTOR OF PHARMACY OPERA	23.00	Key Emp	$116,104	$67,439	$290,110
ANTHONY BETBADAL MD	HEMATOLOGIST	15.00	Highest	$171,795	$82,266	$599,017
BRANDON HARDESTY MD	HEMATOLOGIST	13.00	Highest	$169,365	$78,343	$662,648
DAVID HEDRICK MD	HEMATOLOGIST	13.00	Highest	$167,605	$90,418	$664,379
JAY GADDY MD	HEMATOLOGIST	14.00	Highest	$174,880	$68,990	$643,826
MAGDALENA LEWANDOWSKA MD	HEMATOLOGIST	13.00	Highest	$165,050	$91,525	$659,531

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$39,420,575	$45,183,867	$74,045,300	$-5,763,292
2023	$56,975,342	$56,574,065	$214,000,867	$401,277
2022	$55,708,442	$48,585,161	$205,388,132	$7,123,281
2021	$58,709,453	$45,391,063	$231,660,883	$13,318,390
2020	$47,732,836	$37,172,453	$214,767,252	$10,560,383
2019	$52,304,714	$42,328,804	$185,091,518	$9,975,910

INDIANA HEMOPHILIA & THROMBOSIS CENTER INC